SFDA issues the No.145 announcement of drug administrative protection
eCompany 2010-05-12 13:37:55 Author:SystemMaster
Source:SFDA Font size:[Large][Middle][Small]
The State Food and Drug Administration (SFDA) issued the No.145 Drug Administrative Protection Announcement on May 5, 2010, declaring Ortho-McNeil-Janssen Pharmaceuticals Inc.'s Invega Sustenna (paliperidone palmitate) extended-release injection proceed to substantive examination.
Copyright : China Chamber of Commerce for Import & Export of Medicines & Health Products (CCCMHPIE) Address : 11-12/F, Building3,Beijing INN, No.6 Nanzhugan Hutong, Dongcheng District, Beijing, China Postcode : 100010 Tel : 　86-10-58036282　 86-10-58036280　 　　　Fax : 　86-10-58036284　
